Interim RELIANCE registry data of FMF patients treated with Canakinumab shows efficacy and safety of long-term tx including w/ dose adjustments. Abs 0138 #ACR22 @RheumNow https://t.co/ornfXVIw49 https://t.co/eHTIIEhE37
Links:
Patients with Familial Mediterranean Fever (FMF) Under Canakinumab Treatment - …
http://ow.ly/vIjH50LtM7t
12-11-2022
